Orchid Pharma (ORCHPHARMA)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹566.8 |
| Market Cap | ₹3,143.32 Cr |
| P/E Ratio | 120.99 |
| ROCE | 8.07% |
| ROE | 3.34% |
| Dividend Yield | 0% |
| Profit Growth | -126.47% |
| Debt/Equity | — |
| Sales Growth | -4.63% |
| Promoter Holding | 69.84% |
| 52-Week Range | ₹480 — ₹933.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹261.46 |
Orchid Pharma trades with a P/E ratio of 120.99, ROCE of 8.07%, ROE of 3.34%, profit growth of -126.47%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer